Learn About Genetic Testing for Molybdenum Cofactor Deficiency

Molybdenum cofactor deficiency is a rare inherited metabolic disorder that can affect neurological development and function. It results from impaired production of molybdenum cofactor, which is needed for the activity of several enzymes. Genetic testing plays an important role in confirming the underlying cause when clinical and biochemical findings suggest the condition.

Understanding Genetic Testing for Molybdenum Cofactor Deficiency

Genetic testing examines DNA for disease causing variants in genes associated with molybdenum cofactor production. The condition is primarily associated with changes in MOCS1, MOCS2, MOCS3, and GPHN. Identifying disease causing variants in both copies of one of these genes can establish the molecular diagnosis.

Testing may be considered when a person has neurological or metabolic findings that raise suspicion of molybdenum cofactor deficiency. Common approaches include:

• Multigene panel testing: Examines several genes associated with molybdenum cofactor deficiency and related neurological or metabolic conditions.
• Exome sequencing: Examines protein coding regions across many genes and may be considered when the diagnosis is uncertain.
• Genome sequencing: Provides broader analysis and may be useful when previous testing has not identified the genetic cause.
• Deletion and duplication analysis: May identify certain larger genetic changes that sequence analysis can miss.

Genetic testing is generally interpreted together with clinical findings and biochemical investigations rather than being considered in isolation.

Interpreting Genetic Test Results and Family Risk

A genetic test may identify a pathogenic variant, likely pathogenic variant, variant of uncertain significance, or a result in which no relevant variant is detected. Finding disease causing variants in both copies of an associated gene can support a diagnosis of molybdenum cofactor deficiency. A variant of uncertain significance alone does not establish or exclude the diagnosis.

Because molybdenum cofactor deficiency follows an autosomal recessive inheritance pattern, parents of an affected individual may each carry one disease causing variant without having the condition themselves. Once the familial variants are identified, testing may help assess relatives who could be carriers.

Important considerations include:

• Genetic counseling can help families understand test results and inheritance.
• Carrier testing can be performed when the disease causing variants in a family are known.
• Prenatal testing may be available for pregnancies with an identified familial risk.
• Preimplantation genetic testing may also be discussed with qualified specialists.

Genetic testing for molybdenum cofactor deficiency is an important diagnostic tool for understanding the molecular cause of this rare condition. The choice of test depends on the individual's symptoms, laboratory findings, family history, and previous genetic evaluations. Results should be interpreted by qualified healthcare and genetics professionals alongside other clinical information. Genetic counseling can provide additional information about inheritance, family testing, and reproductive considerations.